These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27140987)

  • 1. Cancer Drugs Provide Positive Value In Nine Countries, But The United States Lags In Health Gains Per Dollar Spent.
    Salas-Vega S; Mossialos E
    Health Aff (Millwood); 2016 May; 35(5):813-23. PubMed ID: 27140987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Market uptake of biologic and small-molecule--targeted oncology drugs in Europe.
    Obradovic M; Mrhar A; Kos M
    Clin Ther; 2009 Dec; 31(12):2940-52. PubMed ID: 20110034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Time-Trend Economic Analysis of Cancer Drug Trials.
    Cressman S; Browman GP; Hoch JS; Kovacic L; Peacock SJ
    Oncologist; 2015 Jul; 20(7):729-36. PubMed ID: 26032135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care expenditure in Sweden--an international comparison.
    Gerdtham UG; Jönsson B
    Health Policy; 1991; 19(2-3):211-28. PubMed ID: 10115993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The return on investment in health care: from 1980 to 2000.
    Luce BR; Mauskopf J; Sloan FA; Ostermann J; Paramore LC
    Value Health; 2006; 9(3):146-56. PubMed ID: 16689708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paying for Prescription Drugs Around the World: Why Is the U.S. an Outlier?
    Sarnak DO; Squires D; Kuzmak G; Bishop S
    Issue Brief (Commonw Fund); 2017 Oct; 2017():1-14. PubMed ID: 28990747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health care expenditures in nine industrialized countries, 1960-76.
    Simanis JG; Coleman JR
    Soc Secur Bull; 1980 Jan; 43(1):3-8. PubMed ID: 6769168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care expenditures: international comparisons, 1970-80.
    Simanis JG
    Soc Secur Bull; 1987 Oct; 50(10):19-24. PubMed ID: 3120328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic value of innovative treatments over the product life cycle: the case of targeted trastuzumab therapy for breast cancer.
    Garrison LP; Veenstra DL
    Value Health; 2009; 12(8):1118-23. PubMed ID: 19624617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost and burden of cancer in the European Union 1995-2014.
    Jönsson B; Hofmarcher T; Lindgren P; Wilking N
    Eur J Cancer; 2016 Oct; 66():162-70. PubMed ID: 27589247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic burden of cancer across the European Union: a population-based cost analysis.
    Luengo-Fernandez R; Leal J; Gray A; Sullivan R
    Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of the pharmaceutical expenditure in Hungary].
    Inotai A; Merész G; Kaló Z
    Acta Pharm Hung; 2010; 80(4):162-72. PubMed ID: 21404477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs.
    Kanavos P; Ferrario A; Vandoros S; Anderson GF
    Health Aff (Millwood); 2013 Apr; 32(4):753-61. PubMed ID: 23569056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International comparison of the factors influencing reimbursement of targeted anti-cancer drugs.
    Lim CS; Lee YG; Koh Y; Heo DS
    BMC Health Serv Res; 2014 Nov; 14():595. PubMed ID: 25432511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How much do we spend on prescription medicines? Out-of-pocket costs for patients in Australia and other OECD countries.
    Kemp A; Preen DB; Glover J; Semmens J; Roughead EE
    Aust Health Rev; 2011 Aug; 35(3):341-9. PubMed ID: 21871197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explaining high health care spending in the United States: an international comparison of supply, utilization, prices, and quality.
    Squires DA
    Issue Brief (Commonw Fund); 2012 May; 10():1-14. PubMed ID: 22582452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Explaining high health care spending in the United States: an international comparison of supply, utilization, prices, and quality.
    Squires DA
    Issue Brief (Commonw Fund); 2012 May; 10():1-14. PubMed ID: 22619775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of permanent and transitory shocks in explaining international health expenditures.
    Narayan PK; Narayan S
    Health Econ; 2008 Oct; 17(10):1171-86. PubMed ID: 18076005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.